Phillips Barclay A Stock Option Grant

Barclay A. Phillips, a director at IMMUNIC, INC., was granted 25,370 stock options on June 29, 2026. These options, which are for the company's Common Stock, have an exercise price of $10.90 and an expiration date of March 27, 2036. The grant was conditionally approved by the Board of Directors on March 27, 2026, and subsequently approved by stockholders at the 2026 Annual Meeting. The options are fully vested as of March 27, 2026. This transaction is reported on Form 4.